524715:BOM
Sun Pharmaceutical Industries Ltd.
1.748,90 INR
arrow_downward
-1,14%(-20,20) 1G
14 ott, 15:30:00 GMT+5:30 · INR
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per 524715 in corso…
Apertura
1.769,10 INR
Massimo
1.777,05 INR
Minimo
1.725,70 INR
Cap. mercato
4,19 Bln
Vol. medio
111,91K
Volume
53,16K
Dividendo
0,91%
Dividendo trimestrale
4,00 INR
Data di stacco dividendo
7 lug 2026
Rapporto P/E
34,67
Max 52 sett.
2.047,55 INR
Min 52 sett.
1.583,60 INR
Utili per azione
50,44 INR
Azioni in circolazione
0,00
N. di dipendenti
47K
Apertura
1.769,10 INR
Massimo
1.777,05 INR
Minimo
1.725,70 INR
Cap. mercato
4,19 Bln
Vol. medio
111,91K
Volume
53,16K
Dividendo
0,91%
Dividendo trimestrale
4,00 INR
Data di stacco dividendo
7 lug 2026
Rapporto P/E
34,67
Max 52 sett.
2.047,55 INR
Min 52 sett.
1.583,60 INR
Utili per azione
50,44 INR
Azioni in circolazione
0,00
N. di dipendenti
47K
Articoli giornalistici
Da fonti web e partner giornalistici
Business Standard
·
1 ora fa
Sun Pharma down 2%, stock hits over 5-month low
ad-hoc-news.de
·
22 ore fa
Geojit raises target for Sun Pharma stock to INR 2,070.00
TipRanks
·
1 giorno fa
Sun Pharma Clears INR 10,000 Crore NCD Plan as Independent Director Resigns
Profilo
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
Informazioni su Sun Pharmaceutical Industries Ltd.
CEO-
Dipendenti47K
Data di fondazione1983
SedeGoregaon East, Mumbai, India
Settore-
Sito websunpharma.com